Alcohol consumption and risk of adult-onset acute myeloid leukemia: results from a Los Angeles County case-control study

Leukemia Research
Janice M PogodaSusan Preston-Martin

Abstract

Few studies have examined the role of alcohol consumption in risk of adult acute myeloid leukemia (AML). Two previous case-control studies resulted in inconsistent findings. We report data from a Los Angeles County population-based case-control study in which 164 matched case-control pairs were asked about lifetime history of alcohol consumption and 136 cases were subtyped according to the French-American-British (FAB) criteria. Estimated categorical odds ratios (OR) adjusted for smoking and education were suggestive of a possible protective effect but trend tests were non-significant. Analyses by FAB subtype did not reveal subtype-specific associations but generally suffered from lack of power. Larger studies are needed to more thoroughly investigate the relationship between alcohol consumption and AML risk.

References

Apr 1, 1994·Internal Medicine·I WakabayashiM ] Shimo-oka M [corrected to Shimo-oku
May 1, 1993·Journal of Studies on Alcohol·B G Embree, P C Whitehead
Mar 8, 2002·American Journal of Epidemiology·Janice M PogodaRonald K Ross
Jun 11, 2003·Archives of Internal Medicine·S Goya WannametheeEric B Rimm

❮ Previous
Next ❯

Citations

Apr 28, 2009·Annals of Epidemiology·Arthur L KlatskyGary D Friedman
Apr 5, 2013·International Journal of Cancer. Journal International Du Cancer·Mirjam M HeinenPiet A van den Brandt
Aug 22, 2006·Leukemia Research·Giuseppe GoriniAdele Seniori Costantini
Sep 18, 2008·The Journal of Behavioral Health Services & Research·Denise Zabkiewicz, Laura A Schmidt
Apr 16, 2009·Social Psychiatry and Psychiatric Epidemiology·Denise Zabkiewicz
Mar 29, 2007·The Journal of Behavioral Health Services & Research·Denise Zabkiewicz, Laura A Schmidt
Feb 14, 2007·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Romain CaseyMarc Maynadié

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.